| Annual Financials | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
Revenue  | 9 | 19 | 24 | 36 | 51 | 57 | 50 | 29 | 16 | 4 | 855 |
| Expenses | 9 | 18 | 23 | 34 | 47 | 54 | 49 | 26 | 13 | 4 | 845 |
| EBITDA | 0 | 1 | 1 | 2 | 3 | 4 | 1 | 3 | 3 | 0 | 10 |
| Operating Profit % | 3 % | 3 % | 2 % | 4 % | 7 % | 2 % | -19 % | -21 % | 7 % | -44 % | -25 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 | 1 | 2 | 2 | 0 | 3 | 3 | 0 | 10 |
| Tax | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 0 | 3 |
| Net Profit | 0 | 0 | 0 | 1 | 2 | 2 | 0 | 2 | 2 | 0 | 8 |
| EPS in ₹ | 11.26 | 10.07 | 5.27 | 29.62 | 53.83 | 2.94 | 0.01 | 0.36 | 0.32 | 0.00 | 0.10 |
Murae Organisor
1.95
+0.09
(4.84%)
Market Cap
181.27 Cr
EPS
0.00
PE Ratio
23.25
Dividend Yield
0.00 %
Industry
Healthcare52 Week High
2.73
52 Week Low
1.04
PB Ratio
0.83
Debt to Equity
0.12
Sector
Pharmaceuticals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,667.30 | #1 4,00,041.12 | 35.03 | #1 49,887.20 | 12.06 | #1 9,648 | -18.99 | 41.82 | |
6,540.00 | 1,73,616.45 | 79.22 | 8,184.00 | 0.89 | 1,600 | 23.05 | 59.58 | |
1,468.30 | 1,18,582.10 | 22.51 | 26,520.70 | 14.17 | 4,155 | 30.28 | 45.47 | |
3,136.20 | 1,06,143.26 | 54.96 | 10,785.70 | 11.59 | 1,656 | 10.91 | 39.95 | |
1,246.70 | 1,04,031.55 | #1 18.43 | 28,905.40 | 12.36 | 5,578 | 21.14 | 65.56 | |
2,356.50 | 97,224.13 | 50.15 | 10,615.60 | 19.57 | 1,942 | -10.91 | 42.84 | |
928.35 | 93,413.73 | 20.02 | 19,831.50 | 13.82 | 3,831 | -0.19 | 62.05 | |
1,954.40 | 89,226.36 | 27.27 | 20,141.50 | #1 19.94 | 1,936 | #1 112.49 | 43.58 | |
1,142.90 | 66,379.82 | 19.10 | 29,559.20 | 17.55 | 3,169 | -0.50 | 41.29 | |
31,060.00 | 66,000.33 | 46.07 | 6,097.20 | 10.80 | 1,201 | 27.83 | 52.43 |
Forecast
Actual
Growth Rate
Revenue Growth
-75.00 %
Net Income Growth
-95.00 %
Cash Flow Change
-6,223.08 %
ROE
-99.06 %
ROCE
-96.36 %
EBITDA Margin (Avg.)
-50.21 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Total Assets | 5 | 9 | 11 | 20 | 23 | 36 | 28 | 29 | 29 | 120 |
| Fixed Assets | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 |
| Current Assets | 5 | 9 | 11 | 19 | 23 | 32 | 27 | 28 | 28 | 120 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 5 | 9 | 11 | 19 | 23 | 35 | 27 | 28 | 28 | 120 |
| Total Liabilities | 5 | 9 | 11 | 20 | 23 | 36 | 28 | 29 | 29 | 120 |
| Current Liabilities | 3 | 7 | 9 | 13 | 15 | 20 | 11 | 12 | 10 | 64 |
| Non Current Liabilities | 1 | 0 | 1 | 2 | 3 | 1 | 2 | 0 | 0 | 0 |
| Total Equity | 1 | 1 | 2 | 5 | 6 | 14 | 15 | 17 | 19 | 56 |
| Reserve & Surplus | 0 | 1 | 1 | 4 | 6 | 8 | 8 | 4 | 6 | 6 |
| Share Capital | 0 | 0 | 0 | 0 | 0 | 6 | 6 | 12 | 12 | 49 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | 0 | 0 | -0 | -0 | 0 | -0 | -1 | 0 | 0 | 12 |
| Investing Activities | 0 | -0 | 0 | -0 | -0 | -4 | 3 | 0 | 0 | -1 |
| Operating Activities | -2 | -0 | 0 | -7 | -1 | -4 | -7 | 3 | 0 | -16 |
| Financing Activities | 2 | 1 | -0 | 7 | 1 | 7 | 3 | -3 | -0 | 28 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | May 2024 | Jun 2024 | Aug 2024 | Sept 2024 | Dec 2024 | Jan 2025 | Mar 2025 |
| Promoter | 70.04 % | 70.04 % | 70.04 % | 70.04 % | 50.21 % | 37.57 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 29.33 % | 28.50 % | 28.39 % | 26.56 % | 45.47 % | 56.92 % | 95.48 % | 95.05 % | 95.01 % | 63.97 % | 95.47 % | 95.34 % | 92.07 % | 91.70 % | 91.62 % | 47.62 % | 47.57 % | 47.12 % | 60.15 % | 60.02 % |
| Others | 0.63 % | 1.46 % | 1.57 % | 3.40 % | 4.32 % | 5.50 % | 4.52 % | 4.95 % | 4.99 % | 36.03 % | 4.53 % | 4.66 % | 7.93 % | 8.30 % | 8.38 % | 52.38 % | 52.43 % | 52.88 % | 39.85 % | 39.98 % |
| No of Share Holders | 46 | 91 | 242 | 10,710 | 24,944 | 26,192 | 30,201 | 31,093 | 30,714 | 30,869 | 48,146 | 52,415 | 58,634 | 58,445 | 55,791 | 56,390 | 54,654 | 62,098 | 60,844 | 78,899 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
No dividends have been distributed by the company in the past 10 years
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 22 May 2025 |  Quarterly Result Announcement | NA | 22 May 2025 | 1.41 | 1.40 |
| 28 Jan 2025 | Quarterly Result Announcement | NA | 28 Jan 2025 | 2.03 | 1.80 |
| 10 Jan 2025 |  Extraordinary General Meeting | NA | 10 Jan 2025 | 2.15 | 1.86 |
| 19 Dec 2024 |  Rights | 1:3 | 19 Dec 2024 | 2.13 | 2.15 |
| 14 Nov 2024 | Quarterly Result Announcement | NA | 14 Nov 2024 | 1.37 | 1.29 |
| 30 Sept 2024 |  Annual General Meeting | NA | 30 Sept 2024 | 1.29 | 1.23 |
| 24 Apr 2024 | Extraordinary General Meeting | NA | 24 Apr 2024 | 1.40 | 1.62 |
| 20 Mar 2024 |  Change Of Name | NA | 20 Mar 2024 | 1.75 | 1.75 |
| Rights | 4:1 | 10 Apr 2023 | 1.81 | 0.00 | |
| 10 Aug 2021 |  Bonus | 1:1 | 09 Aug 2021 | 8.66 | 12.21 |
Announcements
Board Meeting Intimation for Intimation Of Meeting Of Board Of Director Of The Company Scheduled To Be Held On 13-05-2025
3 hours ago
3 hours ago Shareholder Meeting / Postal Ballot-Scrutinizer"s Report2 days ago
2 days agoCompliances-Reg.24(A)-Annual Secretarial Compliance3 days ago
3 days agoIntimation Of Record Date For Sub-Division/Split Of Equity Shares Of The Company Under Regulation 42 Of The SEBI (Listing Obligations And Disclosures Requirement) Regulations 20154 days ago
4 days agoBoard Meeting Outcome for Outcome Of Meeting Of Board Of Director Of The Company Held Today I.E 30Th May 20254 days ago
4 days agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication10 days ago
10 days agoIntegrated Filing (Financial)May 22, 2025
May 22, 2025Financial ResultsMay 22, 2025
May 22, 2025Financial ResultsMay 22, 2025
May 22, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On Today I.E. 22Nd May 2025May 22, 2025
May 22, 2025Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday 22Nd May 2025May 14, 2025
May 14, 2025Rumour verification - Regulation 30(11)May 14, 2025
May 14, 2025Intimation Of Proposed Acquisition Of Land For Agricultural And Industrial Expansion & Investment Of INR 250 MillionMay 12, 2025
May 12, 2025Announcement under Regulation 30 (LODR)-Change in Registered Office AddressMay 07, 2025
May 07, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On Today I.E. 7Th May 2025May 07, 2025
May 07, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotApr 29, 2025
Apr 29, 2025Board Meeting Outcome for Outcome Of Board Meeting Dated April 24Th 2025 Along With Additional Details
As Per SEBI Circular Dated 13.07.2023 Regarding Disclosure Of Material Events/
Information By Listed Entities Under Regulations 30 And 30A Of SEBI (LApr 24, 2025
Apr 24, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 22, 2025
Apr 22, 2025Board Meeting Intimation for Intimation Of Board Meeting To Consider Stock Split Under SEBI (LODR) Regulations 2015Apr 21, 2025
Apr 21, 2025Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerApr 04, 2025
Apr 04, 2025Announcement under Regulation 30 (LODR)-Resignation of DirectorApr 01, 2025
Apr 01, 2025Annoucement Under Regulation 30 Of SEBI (LODR) Regulations 2015- Reconstitution Of Committee.Mar 29, 2025
Mar 29, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateMar 29, 2025
Mar 29, 2025Board Meeting Outcome for Outcome And Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 29, 2025
Mar 29, 2025Closure of Trading WindowMar 29, 2025
Mar 29, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateMar 21, 2025
Mar 21, 2025Announcement under Regulation 30 (LODR)-Resignation of DirectorMar 21, 2025
Mar 21, 2025Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Feb 20, 2025
Feb 20, 2025Integrated Filing (Financial)Feb 14, 2025
Feb 14, 2025Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Thursday 13Th February 2025Feb 13, 2025
Feb 13, 2025Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations
And Disclosure Requirements) Regulations 2015Feb 07, 2025
Feb 07, 2025Rumour verification - Regulation 30(11)Jan 31, 2025
Jan 31, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 29, 2025
Jan 29, 2025Integrated Filing (Financial)Jan 28, 2025
Jan 28, 2025Submission Of Unaudited Financial Results For The Quarter And Nine Months
Ended On 31St December 2024 Along With Limited Review ReportJan 28, 2025
Jan 28, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On Today I.E. 28Th January 2025Jan 28, 2025
Jan 28, 2025Intimation Of Trading Approval Received For Rights Issue Of Fully Paid-Up Equity Shares By Murae Organisor Limited (Formerly Known As Earum Pharmaceuticals Limited) (The Company) Under Regulation 30 OJan 24, 2025
Jan 24, 2025Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Tuesday 28Th January 2025Jan 23, 2025
Jan 23, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 23, 2025
Jan 23, 2025Board Meeting Outcome for Rights Issue Committee Approves Allotment Of Shares W.R.T. Rights Issue Of The CompanyJan 17, 2025
Jan 17, 2025Submission Of Voting Results Of Extra Ordinary General Meeting Of The Company Under Regulation 44(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 13, 2025
Jan 13, 2025Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJan 13, 2025
Jan 13, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 13, 2025
Jan 13, 2025Shareholder Meeting / Postal Ballot-Outcome of EGMJan 10, 2025
Jan 10, 2025Closure of Trading WindowDec 31, 2024
Dec 31, 2024Addendum To Notice Of The Extra-Ordinary General Meeting (EGM) Of Murae Organisor Limited (Formerly Known As Earum Pharmaceuticals Limited) To Be Held On Friday 10Th January 2025 At 03:00 P.M. ThroughDec 23, 2024
Dec 23, 2024Intimation Of Record Date For Issue Of Equity Shares On Rights ('Rights Issue')Dec 13, 2024
Dec 13, 2024Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sDec 13, 2024
Dec 13, 2024Board Meeting Outcome for Intimation And Outcome Of Board Meeting Held Today I.E., 13Th December, 2024 As Per The Regulation 30 Of SEBI (LODR) Regulation, 2015Dec 13, 2024
Dec 13, 2024Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Friday, 13Th December, 2024Dec 10, 2024
Dec 10, 2024Technical Indicators
RSI(14)
Neutral 68.90
ATR(14)
Less Volatile 0.08
STOCH(9,6)
Overbought 95.68
STOCH RSI(14)
Overbought 100.00
MACD(12,26)
Bullish 0.06
ADX(14)
Weak Trend 17.22
UO(9)
Bearish 85.84
ROC(12)
Uptrend And Accelerating 20.00
WillR(14)
Overbought 0.00
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
